Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
High Intensity Focused Ultrasound Therapy Market: By Application, By Modality, By Method, By End User, and Region Forecast 2021-2032
High Intensity Focused Ultrasound Therapy Market size was valued at US$ 109.0 million in 2025 and is expected to reach US$ 172.8 million by 2032, growing at a significant CAGR of 6.8% from 2026-2032. High-frequency sound waves are employed in market to kill cancer cells. It can only treat a single tumour or a portion of a larger tumour; it cannot be utilised to treat tumours that are widespread. As a result, High Intensity Focused Ultrasound (HIFU) Market is ineffective in the treatment of malignant tumours. Ultrasound waves propagate through tissue medium as energy carriers in this therapy, which is new and emerging. Tumor ablation, hemostasis, thrombolysis, and targeted drug/gene delivery are all possible with HIFU therapy, which is completely non-invasive. Using high-frequency ultrasound waves, the therapy is also utilised to treat prostate cancer. Because of its non-invasiveness, sharp treatment margins, and low complication rates, it is widely employed in interventional oncology.
Furthermore, over the projection period, the application of the technology in conjunction with other therapeutic and diagnostic modalities, such as targeted drug/gene delivery, robotic surgery, and molecular imaging, is predicted to develop and have a revolutionary clinical impact. Prostate cancer, kidney cancer, primary and secondary liver cancer, pancreatic cancer, and bladder cancer will all see increased occurrence, boosting the market's growth. According to the American Cancer Society, there were around 161,360 new cases of prostate cancer diagnosed in the United States in 2016. Furthermore, the market's expansion has been propelled by the rapid advancement of medical technology and its wide variety of applications in the treatment of uterine fibroids, neurological disorders, cosmetic medicine, and other conditions.
Study Period
2026-2032Base Year
2025CAGR
6.8%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
The HIFU Therapy Market owing to increasing prevalence of various cancers, such as prostate cancer, kidney cancer, primary and secondary liver cancer, pancreatic cancer, and bladder cancer and rising development in the medical technology are the major factors that are driving the growth of the market. Moreover, rising prevalence of cardiovascular diseases and rapidly growing ageing population and launch of new products fuels the growth of the market. However, stringent regulations and unfavorable reimbursement scenario may hinder the growth of the market.
|
Report Benchmarks |
Details |
|
Report Study Period |
2026-2032 |
|
Market CAGR |
6.8% |
|
By Application |
|
|
By Modality |
|
|
By Method |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
High intensity focused ultrasound therapy market size was valued at US$ 109.0 million in 2025 and is expected to reach US$ 172.8 million by 2032, growing at a significant CAGR of 6.8% from 2026-2032.
increasing prevalence of various cancers.
North America is the fastest-growing region in the market.
Content Updated Date: Feb 2026
| 1.Executive Summary |
| 2.Global High Intensity Focused Ultrasound Therapy Market Introduction |
| 2.1.Global High Intensity Focused Ultrasound Therapy Market - Taxonomy |
| 2.2.Global High Intensity Focused Ultrasound Therapy Market - Definitions |
| 2.2.1.Application |
| 2.2.2.Modality |
| 2.2.3.Method |
| 2.2.4. End User |
| 2.2.5.Region |
| 3.Global High Intensity Focused Ultrasound Therapy Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global High Intensity Focused Ultrasound Therapy Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 |
| 4.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global High Intensity Focused Ultrasound Therapy Market By Application, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 5.1. Prostate Cancer |
| 5.1.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Neurological Disorders |
| 5.2.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Uterine Fibroids |
| 5.3.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Aesthetics |
| 5.4.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Others |
| 5.5.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6.Global High Intensity Focused Ultrasound Therapy Market By Modality, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 6.1. Therapeutic Ultrasound |
| 6.1.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Hemostasis |
| 6.2.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global High Intensity Focused Ultrasound Therapy Market By Method, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 7.1. Non-Invasive Method |
| 7.1.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Minimal-Invasive Method |
| 7.2.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8.Global High Intensity Focused Ultrasound Therapy Market By End User, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 8.1. Hospitals |
| 8.1.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Research Centers |
| 8.2.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Diagnostic Centers |
| 8.3.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9.Global High Intensity Focused Ultrasound Therapy Market By Region, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America High Intensity Focused Ultrasound Therapy Market ,2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 10.1. Application Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Prostate Cancer |
| 10.1.2.Neurological Disorders |
| 10.1.3.Uterine Fibroids |
| 10.1.4.Aesthetics |
| 10.1.5.Others |
| 10.2. Modality Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Therapeutic Ultrasound |
| 10.2.2.Hemostasis |
| 10.2.3.Others |
| 10.3. Method Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Non-Invasive Method |
| 10.3.2.Minimal-Invasive Method |
| 10.4. End User Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospitals |
| 10.4.2.Research Centers |
| 10.4.3.Diagnostic Centers |
| 10.5. Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe High Intensity Focused Ultrasound Therapy Market ,2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 11.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Prostate Cancer |
| 11.1.2.Neurological Disorders |
| 11.1.3.Uterine Fibroids |
| 11.1.4.Aesthetics |
| 11.1.5.Others |
| 11.2. Modality Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Therapeutic Ultrasound |
| 11.2.2.Hemostasis |
| 11.2.3.Others |
| 11.3. Method Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Non-Invasive Method |
| 11.3.2.Minimal-Invasive Method |
| 11.4. End User Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospitals |
| 11.4.2.Research Centers |
| 11.4.3.Diagnostic Centers |
| 11.5. Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 12.Asia Pacific (APAC) High Intensity Focused Ultrasound Therapy Market ,2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 12.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Prostate Cancer |
| 12.1.2.Neurological Disorders |
| 12.1.3.Uterine Fibroids |
| 12.1.4.Aesthetics |
| 12.1.5.Others |
| 12.2. Modality Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Therapeutic Ultrasound |
| 12.2.2.Hemostasis |
| 12.2.3.Others |
| 12.3. Method Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Non-Invasive Method |
| 12.3.2.Minimal-Invasive Method |
| 12.4. End User Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospitals |
| 12.4.2.Research Centers |
| 12.4.3.Diagnostic Centers |
| 12.5. Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) High Intensity Focused Ultrasound Therapy Market ,2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 13.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Prostate Cancer |
| 13.1.2.Neurological Disorders |
| 13.1.3.Uterine Fibroids |
| 13.1.4.Aesthetics |
| 13.1.5.Others |
| 13.2. Modality Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Therapeutic Ultrasound |
| 13.2.2.Hemostasis |
| 13.2.3.Others |
| 13.3. Method Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Non-Invasive Method |
| 13.3.2.Minimal-Invasive Method |
| 13.4. End User Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospitals |
| 13.4.2.Research Centers |
| 13.4.3.Diagnostic Centers |
| 13.5. Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America High Intensity Focused Ultrasound Therapy Market ,2021 - 2025 and Forecast 2026 - 2032 (Sales Value USD Million) |
| 14.1. Application Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Prostate Cancer |
| 14.1.2.Neurological Disorders |
| 14.1.3.Uterine Fibroids |
| 14.1.4.Aesthetics |
| 14.1.5.Others |
| 14.2. Modality Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Therapeutic Ultrasound |
| 14.2.2.Hemostasis |
| 14.2.3.Others |
| 14.3. Method Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Non-Invasive Method |
| 14.3.2.Minimal-Invasive Method |
| 14.4. End User Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Hospitals |
| 14.4.2.Research Centers |
| 14.4.3.Diagnostic Centers |
| 14.5. Country Analysis 2021 - 2025 and Forecast 2026 - 2032 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Koninklijke Philips N.V. |
| 15.2.2.Image Guided Therapy |
| 15.2.3.EDAP |
| 15.2.4.SonaCare Medical, LLC. |
| 15.2.5.Chongqing Haifu Medical Technology Co., Ltd. |
| 15.2.6.Promedica Bioelectronics s.r.l. |
| 15.2.7.MIANYANG SONIC ELECTRONIC |
| 15.2.8.INSIGHTEC Ltd. |
| 15.2.9.ALPINION MEDICAL SYSTEMS Co., Ltd. |
| 15.2.10.FUS Instruments |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players